Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alnylam pharmaceuticals
3
×
boston blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sanofi
3
×
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
astrazeneca
biotech
boston top stories
clinical trials
deals
fda
givosiran
m&a
novartis
startups
2019
abbvie
abeona therapeutics
What
bio
3
×
roundup
acquisitions
advanced
alnylam’s
alzheimer’s
announced
approval
bff
ceo
collabs
conference
congress
covid
daniel
deal
deals
democrats
devoted
disease
divided
drug
easl
elections
fallout
form
gene
gilead
gilead’s
help
introduce
ipo
kicked
liver
losses
major
medicines
midterm
month
o’day
Language
unset
Current search:
sanofi
×
bio
×
" alnylam pharmaceuticals "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel